Todd Gould - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Todd Gould's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Todd Gould

Todd Gould

Verified

Senior Television Producer and Director, WTIU-TV (Bloomington, IN)

Final Covers

& Personal Development Wellness Leadershipcreativity

Industries

-

Medium Formats

Content

Total articles 11

  • Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity - Neuropsychopharmacology

    By Todd Gould| Nature Verified AbstractThe pharmacologically active (R,S)-ketamine (ketamine) metabolite (2 R,6 R)-hydroxynorketamine (HNK) maintains ketamine’s preclinical antidepressant profile without adverse effects. While hypotheses have been proposed to explain how ketamine and its metabolites initiate their antidepressant-relevant effects, it remains unclear how sustained therapeutic actions arise following drug elimination.

    By Todd Gould · Nature

    Mar. 16, 2025

  • RAPID HIPPOCAMPAL SYNAPTIC POTENTIATION INDUCED BY KETAMINE METABOLITE (2R,6R)-HYDROXYNORKETAMINE PERSISTENTLY PRIMES SYNAPTIC PLASTICITY

    By Kyle Brown, Todd Gould, Musa I Ajibola| bioRxiv@ AbstractThe pharmacologically active (R,S)-ketamine (ketamine) metabolite (2R,6R)-hydroxynorketamine (HNK) maintains ketamine's preclinical antidepressant profile without adverse effects. While hypotheses have been proposed to explain how ketamine and its metabolites initiate their antidepressant-relevant effects, it remains unclear how sustained therapeutic actions arise following drug elimination.

    By Kyle Brown, Todd Gould, Musa I Ajibola · bioRxiv

    Oct. 22, 2024

  • Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity - Neuropsychopharmacology

    By Todd Gould| Nature Verified AbstractThe pharmacologically active (R,S)-ketamine (ketamine) metabolite (2 R,6 R)-hydroxynorketamine (HNK) maintains ketamine’s preclinical antidepressant profile without adverse effects. While hypotheses have been proposed to explain how ketamine and its metabolites initiate their antidepressant-relevant effects, it remains unclear how sustained therapeutic actions arise following drug elimination.

    By Todd Gould · Nature

    Mar. 16, 2025

As seen in

Company Info

WTIU-TV (Bloomington, IN)